# Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide

> **NCT01301963** · PHASE3 · TERMINATED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 9 (actual)

## Conditions studied

- Refractory Multiple Myeloma

## Interventions

- **DRUG:** plerixafor
- **BIOLOGICAL:** filgrastim

## Key facts

- **NCT ID:** NCT01301963
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2013-06
- **Final completion:** —
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2014-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01301963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01301963, "Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01301963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*